←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy, Gastric and Esophageal
Ronan Kelly
MD, MBA
🏢Baylor University Medical Center🌐USA
Director, Charles A. Sammons Cancer Center
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ronan Kelly led CheckMate-577 establishing adjuvant nivolumab as a standard of care for esophageal and GEJ cancer with residual disease after neoadjuvant chemoradiation and surgery. He directs the Charles A. Sammons Cancer Center at Baylor. His work has reshaped perioperative IO in upper GI cancer.
Share:
🧪Research Fields 研究领域
CheckMate-577
adjuvant nivolumab esophageal
upper GI immunotherapy
perioperative IO
GEJ cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ronan Kelly 的研究动态
Follow Ronan Kelly's research updates
留下邮箱，当我们发布与 Ronan Kelly（Baylor University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment